{
    "organizations": [],
    "uuid": "eb4ca4a72fd56a74287d1c6bf951cf67f54a6fd7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-laurus-labs-says-us-fda-completed/brief-laurus-labs-says-us-fda-completed-unit-2-audit-without-observations-idUSL4N1QJ4WU",
    "ord_in_thread": 0,
    "title": "Laurus Labs Says US FDA completed Unit 2 audit without observations",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 1 (Reuters) - Laurus Labs Ltd:\n* Says US FDA completed audit without observations at formulations Unit 2 from Feb 26 to March 1, 2018 Source text for Eikon: ( bit.ly/2GWa3QK )\n ",
    "published": "2018-03-01T22:17:00.000+02:00",
    "crawled": "2018-03-02T20:15:45.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "laurus",
        "lab",
        "ltd",
        "say",
        "u",
        "fda",
        "completed",
        "audit",
        "without",
        "observation",
        "formulation",
        "unit",
        "feb",
        "march",
        "source",
        "text",
        "eikon"
    ]
}